Researchers have developed a "man-made" scorpion venom to be used in the treatment of brain tumours. The venom is used as a carrier to deliver radioactive iodine into tumour cells left behind after surgery has removed the bulk of the tumour. So far the technique has been tested in 18 patients and further trials are under way, a report in the Journal of Clinical Oncology says. Initial findings suggest the treatment is well-tolerated and may be effective. Gliomas are a particularly aggressive form of brain tumours, with only 8% of patients surviving two years and 3% surviving five years from the time of diagnosis. Despite advances in surgery, radiotherapy and chemotherapy, there has been little improvement in length of survival for patients with gliomas. Researchers at Cedars-Sinai Medical Center, in California, carried out a study using TM-601, a synthetic version of a peptide, that naturally occurs in the venom of the Giant Yellow Israeli scorpion. Unlike many substances, the peptide can pass through the bloodstream into the brain and can bind to glioma cells. Patients in the study first had surgery to remove their tumour. Then 14 to 28 days later, a single, low dose of TM-601 with radioactive iodine attached was injected into the cavity from which the tumour had been removed. (C)BBC

Keyword: Glia; Neurotoxins
Link ID: 9186 - Posted: 07.31.2006

US scientists have found a way to reverse muscular dystrophy (MD) in mice, offering hope of a cure for humans with muscle-wasting diseases. The animals in the Nature Genetics study had myotonic dystrophy - the most common form of MD in adults. The therapy targets a particular kind of toxic molecule to "silence" its presence in the diseased muscle. The University of Virginia team showed the treatment fully restored heart and skeletal muscle function in mice. In myotonic dystrophy, like the other types of MD, faulty DNA is to blame for the abnormalities that occur. Myotonic dystrophy occurs because of a large expansion of DNA code, which most likely causes an accumulation of toxic messenger RNA molecules in cells. Messenger or mRNA is a copy of the information carried by a gene on the DNA. If the DNA code is faulty then the mRNA will be faulty too. These abnormalities lead to the progressive muscle weakness and wasting and heart problems seen in myotonic dystrophy. Dr Mani Mahadevan and his team reasoned that eliminating the toxic mRNA molecules might help reverse the disease. They created mice with faulty DNA that could be turned on and off by adding or removing an antibiotic to their drinking water. In the "on" phase the mice showed all the cardinal features of myotonic dystrophy. When the DNA was turned off, normal skeletal and cardiac muscle function was restored in many, but not all of the mice. (C)BBC

Keyword: Muscles
Link ID: 9185 - Posted: 07.31.2006

A visually impaired artist and poet at the Massachusetts Institute of Technology has collaborated with an optics expert to create a visionary new "Seeing Machine" that could assist people who are visually impaired due to eye diseases like macular degeneration. This ScienCentral News video has more. A combination of eye diseases left M.I.T. poet and artist Elizabeth Goldring with only partial eyesight. During one exam, doctors used a device called a Scanning Laser Ophthalmoscope, or "SLO," that projects images onto the retina - the part of the eye that turns light into sight. It's used for determining the severity of vision loss, but Goldring "saw" it could do much more. "I asked them if they could write a word, and they wrote the word 'sun,' she recalls. "I saw that too, and it was the first word I'd seen for many months." Goldring collaborated with the machine's inventor, Robert Webb of the Schepens Eye Research Institute, 30 M.I.T. students, and some of her personal eye doctors to create a smaller, more affordable device they call a "Seeing Machine." "I was a poet before I became visually challenged and part of the reason I felt so strongly about developing the Seeing Machine was in an effort to keep my visual sense alive and active so that I could continue to be a visual artist and poet," says Goldring. © ScienCentral, 2000-2006.

Keyword: Vision
Link ID: 9184 - Posted: 06.24.2010

Helen Pearson On that dream date, something really might be in the air. Results from a mouse study may bolster the evidence for human pheromones, the long-debated chemical signals thought to unconsciously sway our behaviour. A team at the Fred Hutchinson Cancer Research Center in Seattle, Washington, has identified a class of protein receptor in the lining of mouse noses that may also operate in humans. Researchers know that certain chemicals in mouse urine can alter the social or sexual behaviour of other mice. These chemicals work partly by binding to receptors in a particular structure in the mouse nose, known as the vomeronasal organ. In humans, however, this organ is thought to be defunct and the role of pheromones is hotly debated. Finding such receptors in the lining of the nose, rather the vomeronasal organ, is a more direct parallel with humans. Stephen Liberles and Linda Buck report their finding online this week in Nature (S. D. Liberles & L. B. Buck Nature doi:10.1038/nature05066; 2006). They isolated a group of receptors that can be triggered by at least one known mouse pheromone. ©2006 Nature Publishing Group

Keyword: Chemical Senses (Smell & Taste)
Link ID: 9183 - Posted: 06.24.2010

Roxanne Khamsi A new type of drug which increases blood flow to the vagina in animal experiments has now been shown to be safe in rats. Derived from an experimental heart drug, the new compounds could one day help treat women who find it difficult or impossible to become sexually aroused, say researchers at the drugs company Pfizer. Previous tests have shown that the new compounds, including the most potent one, called R-13, increased vaginal blood flow in animals. New tests now demonstrate that the drugs are safely tolerated by rats. The ultimate aim is to address female sexual arousal disorder (FSAD) in women. The condition sometimes involves blood flow problems in the pelvic region, which might be restored by a drug intervention. Experts agree the approach might eventually benefit the small subset of women who suffer sexual dysfunction due to a physiological cause, due to nerve damage in the pelvic area from surgery, for example. But they stress that such drugs would not effectively treat FSAD when it is due to purely psychological factors. In fact, some question the very existence of FSAD, adding that some women’s sexual dissatisfaction may have to do with the nature of the relationship the women are in. © Copyright Reed Business Information Ltd.

Keyword: Sexual Behavior
Link ID: 9182 - Posted: 06.24.2010

By Michael Balter If you've ever worried about leaving the safety of one job for the excitement of another, or contemplated an extramarital affair, chances are you experienced conflict anxiety--the nervousness that occurs when we have to choose between competing impulses. Now, researchers working with mice believe they have identified the part of the brain responsible for this mental anguish. The discovery may aid the search for better drugs for anxiety and other emotional disorders. The neural basis of anxiety first began to become clear in the 1980s, when researchers discovered that a drug used to treat anxiety stimulates receptors for a neurotransmitter called serotonin. More recent research has confirmed this connection (ScienceNOW, 27 March 2002), but scientists still know very little about the role that serotonin plays and where in the brain it acts. To explore this role further, a team led by neurobiologist Jay Gingrich of Columbia University knocked out a gene in mice that encodes a serotonin receptor called 5HT2A, one of more than a dozen such receptors identified to date. 5HT2A is abundant in several areas of the brain and is thought to be involved in conflict anxiety. The researchers put the mice through a battery of tests designed to induce a conflict between safety and novelty-seeking behavior. In one experiment, the team recorded how much time the mice spent in dark versus brightly lit spaces. In another, the researchers placed the mice in an elevated maze, where some sections were completely open and others had walls. Compared to control mice, the knockout animals spent significantly more time engaged in novelty-seeking behavior. For example, they spent twice as much time in the brightly lit part of the cage, which mice usually avoid, Gingrich and his colleagues report in tomorrow's Science. © 2006 American Association for the Advancement of Science.

Keyword: Emotions
Link ID: 9181 - Posted: 06.24.2010

Ann Arbor, Mich. -- Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors. In fact, close relatives of people with OCD are up to nine times more likely to develop OCD themselves. Now, new research is shedding new light on one of the genetic factors that may contribute to that pattern. And while no one gene "causes" OCD, the research is helping scientists confirm the importance of a particular gene that has been suspected to play a major role in OCD's development. In two papers published simultaneously in the Archives of General Psychiatry, researchers from the University of Michigan, the University of Illinois at Chicago, the University of Chicago and the University of Toronto report finding an association between OCD patients and a glutamate transporter gene called SLC1A1. The gene encodes a protein called EAAC1 that regulates the flow of a substance called glutamate in and out of brain cells. So, variations in the gene might lead to alterations in that flow, perhaps putting a person at increased risk of developing OCD. The new findings are especially important not only because of the simultaneous discoveries reported in the papers, but also because of previous studies that show a functional link between glutamate and OCD. Brain imaging and spinal fluid studies have shown differences in the glutamate system between OCD patients and healthy volunteers, including in areas of the brain where the EAAC1 protein is most common.

Keyword: OCD - Obsessive Compulsive Disorder; Genes & Behavior
Link ID: 9180 - Posted: 07.28.2006

A drug made to enhance memory appears to trigger a natural mechanism in the brain that fully reverses age-related memory loss, even after the drug itself has left the body, according to researchers at UC Irvine. Professors Christine Gall and Gary Lynch, along with Associate Researcher Julie Lauterborn, were among a group of scientists who conducted studies on rats with a class of drugs known as ampakines. Ampakines were developed in the early 1990s by UC researchers, including Lynch, to treat age-related memory impairment and may be useful for treating a number of central nervous system disorders, such as Alzheimer’s disease and schizophrenia. In this study, the researchers showed that ampakine drugs continue to reverse the effects of aging on a brain mechanism thought to underlie learning and memory even after they are no longer in the body. They do so by boosting the production of a naturally occurring protein in the brain necessary for long-term memory formation. The study appears in the August issue of the Journal of Neurophysiology. “This is a significant discovery,” said Gall, professor of anatomy and neurobiology. “Our results indicate the exciting possibility that ampakines could be used to treat learning and memory loss associated with normal aging.” © Copyright 2002-2006 UC Regents

Keyword: Learning & Memory; Alzheimers
Link ID: 9179 - Posted: 06.24.2010

Doctors are testing a radical new way to help smokers quit: a shot that "immunizes" them against the nicotine rush that fuels their addiction. More than 300 people around the country are testing an experimental vaccine that makes the immune system attack nicotine in much the same way it would fight a life-threatening germ. The treatment keeps nicotine from reaching the brain, making smoking less pleasurable and theoretically, easier to give up. The small amount that still manages to get in helps to ease withdrawal, the main reason most quitters relapse. If it works — and this has not yet been proved — the vaccine could become part of a new generation of smoking cessation treatments. They attack dependency in the brain instead of just replacing the nicotine from cigarettes in a less harmful way, like the gum, lozenges, patches and nasal sprays sold today. One such drug, Pfizer Inc.'s Chantix, is due on the market any day now. Another, Sanofi-Aventis SA's Acomplia, recently won approval in Europe as a weight-loss drug. If U.S. regulators follow suit, some doctors say they also will use it to help smokers quit, especially those concerned about gaining weight. © 2006 Discovery Communications Inc.

Keyword: Drug Abuse
Link ID: 9178 - Posted: 06.24.2010

Riverside, Calif. -- UCR researchers have made a major leap forward in understanding how the brain programs innate behavior. The discovery could have future applications in engineering new behaviors in animals and intelligent robots. Innate or "instinctive" behaviors are inborn and do not require learning or prior experience to be performed. Examples include courtship and sexual behaviors, escape and defensive maneuvers, and aggression. Using the common fruit fly as a model organism, the researchers found through laboratory experiments that the innate behavior is initiated by a "command" hormone that orchestrates activities in discrete groups of peptide neurons in the brain. Peptide neurons are brain cells that release small proteins to communicate with other brain cells and the body. The researchers report that the command hormone, called ecdysis-triggering hormone or ETH, activates discrete groups of brain peptide neurons in a stepwise manner, making the fruit fly perform a well-defined sequence of behaviors. The researchers propose that similar mechanisms could account for innate behaviors in other animals and even humans. Study results appear as the cover article in this week's issue of Current Biology. "To our knowledge, we are the first to describe how a circulating hormone turns on sequential steps of an innate behavior by inducing programmed release of brain chemicals," said Young-Joon Kim, a postgraduate researcher in UCR's Department of Entomology working with Michael Adams.

Keyword: Hormones & Behavior
Link ID: 9177 - Posted: 07.28.2006

Zeeya Merali PIT vipers and boid snakes strike at prey with uncanny accuracy even when blindfolded, a feat that's been hard to explain given the rudimentary nature of their heat-sensing organs. It seems that some rather spectacular image processing may be the key. To scout for cool shelters, and hunt in complete darkness, pit vipers and boid snakes are known to use infrared sensing organs. But their skill has amazed scientists. "In the lab, blindfolded snakes can strike a running rat behind the ears to avoid its sharp teeth," says physicist Leo van Hemmen of the Technical University of Munich in Germany. "It must be seeing more than just a warm blob." But how, given that the snakes are saddled with very crude heat-sensing apparatus? On each side of their face, they have a pit organ that is little more than a hole with a heat-sensitive membrane stretched across it. "The eye has a lens to focus a visual image, but these holes can't do that," says van Hemmen. Instead, the pit organs are supposed to work as "pinhole" cameras, except that the holes are too large at 1 millimetre or more in diameter. "These must produce images that are just fuzzy blurs," says van Hemmen. "So, how can the snakes strike with such precision?" © Copyright Reed Business Information Ltd.

Keyword: Vision
Link ID: 9176 - Posted: 06.24.2010

By C. CLAIBORNE RAY Q. Is left-handedness less common in women? A. Studies of Western populations usually find that left-handedness is somewhat less common in women, but perhaps because left-handedness is hard to define, the difference varies by several percentage points. One large study in 1971 used a standard called the Edinburgh Handedness Inventory, which asks which hand is used for different tasks, and found that 90 percent of women were right-handed, as against 86 percent of men. But a smaller 1988 study using the same inventory found no significant difference by sex, and a large Internet study done for the BBC for another purpose found sex differences that varied by ethnic group. Anthropologists’ studies of traditional cultures in Africa and elsewhere found a wide range of differences, from no left-handed women at all to levels approximating those in Western studies. Some researchers have suggested that the trend for more men to be left-handed is not universal or may be affected by social norms, with left-handed men stubbornly clinging to left-handedness while left-handed women are more easily persuaded to join the majority. Copyright 2006 The New York Times Company

Keyword: Laterality; Sexual Behavior
Link ID: 9175 - Posted: 06.24.2010

By NICHOLAS WADE On an animal-breeding farm in Siberia are cages housing two colonies of rats. In one colony, the rats have been bred for tameness in the hope of mimicking the mysterious process by which Neolithic farmers first domesticated an animal still kept today. When a visitor enters the room where the tame rats are kept, they poke their snouts through the bars to be petted. The other colony of rats has been bred from exactly the same stock, but for aggressiveness instead. These animals are ferocious. When a visitor appears, the rats hurl themselves screaming toward their bars. “Imagine the most evil supervillain and the nicest, sweetest cartoon animal, and that’s what these two strains of rat are like,” said Tecumseh Fitch, an animal behavior expert at the University of St. Andrews in Scotland who several years ago visited the rats at the farm, about six miles from Akademgorodok, near the Siberian city of Novosibirsk. Frank Albert, a graduate student at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, is working with both the tame and the hyperaggressive Siberian strains in the hope of understanding the genetic basis of their behavioral differences. “The ferocious rats cannot be handled,” Mr. Albert said. “They will not tolerate it. They go totally crazy if you try to pick them up.” Copyright 2006 The New York Times Company

Keyword: Aggression; Genes & Behavior
Link ID: 9174 - Posted: 06.24.2010

By Philip E. Ross A man walks along the inside of a circle of chess tables, glancing at each for two or three seconds before making his move. On the outer rim, dozens of amateurs sit pondering their replies until he completes the circuit. The year is 1909, the man is José Raúl Capablanca of Cuba, and the result is a whitewash: 28 wins in as many games. The exhibition was part of a tour in which Capablanca won 168 games in a row. How did he play so well, so quickly? And how far ahead could he calculate under such constraints? "I see only one move ahead," Capablanca is said to have answered, "but it is always the correct one." He thus put in a nutshell what a century of psychological research has subsequently established: much of the chess master's advantage over the novice derives from the first few seconds of thought. This rapid, knowledge-guided perception, sometimes called apperception, can be seen in experts in other fields as well. Just as a master can recall all the moves in a game he has played, so can an accomplished musician often reconstruct the score to a sonata heard just once. And just as the chess master often finds the best move in a flash, an expert physician can sometimes make an accurate diagnosis within moments of laying eyes on a patient. But how do the experts in these various subjects acquire their extraordinary skills? How much can be credited to innate talent and how much to intensive training? Psychologists have sought answers in studies of chess masters. The collected results of a century of such research have led to new theories explaining how the mind organizes and retrieves information. What is more, this research may have important implications for educators. Perhaps the same techniques used by chess players to hone their skills could be applied in the classroom to teach reading, writing and arithmetic. © 1996-2006 Scientific American, Inc.

Keyword: Intelligence
Link ID: 9173 - Posted: 06.24.2010

Prior research has shown that chronic alcoholism is associated with numerous olfactory deficits in odor judgment, odor identification, odor sensitivity, and the ability to qualitatively discriminate between odors. New findings indicate that olfactory deficits among alcoholics are associated with prefrontal cognitive dysfunction, specifically, impairment in the functional integrity of the prefrontal lobe. Results are published in the August issue of Alcoholism: Clinical & Experimental Research. "Both frontal and medial temporal lobe brain regions play a major role in olfactory functioning, particularly in the abilities of odor quality discrimination and identification," said Claudia I. Rupp, clinical neuropsychologist and assistant professor in the department of psychiatry at Innsbruck Medical University, and corresponding author for the study. "Given that alcohol can cause brain damage and dysfunction in frontal and medial temporal brain regions, and that neuropsychological tasks such as executive function and memory may represent sensitive measures of the integrity of these brain areas, we were interested in whether olfactory deficits in alcohol dependence are related to executive dysfunctions or memory impairments," she said.

Keyword: Drug Abuse; Chemical Senses (Smell & Taste)
Link ID: 9172 - Posted: 07.25.2006

Rochester, Minn. -- According to a new study, men transmit multiple sclerosis (MS) to their children 2.2 times more often than women in families where the father or mother and a child have multiple sclerosis. This study involved an investigation of 444 children of an MS-affected father or mother from 3,598 individuals in 206 families to compare the transmission of MS between affected men and women. The findings by researchers from Mayo Clinic, the University of California at San Francisco, the University of California at Berkeley and Kaiser Permanente will be published in the July 25 issue of the journal Neurology. "Fathers with MS tend to have more children who develop MS than do mothers with the disease," says Brian Weinshenker, M.D., Mayo Clinic neurologist and study investigator. "When we looked at a large population of MS patients, when there was a parent and a child who had MS in a family, the child with MS got the disease twice as often from the father rather than the mother." MS affects approximately 1 in 1,000 people, and it is twice as common in women as in men. In 85 percent of cases, no cause is known. For 15 percent of MS patients, a family member within a generation also is affected by the disease. For familial cases, no single gene has been identified that strongly predisposes a person to MS.

Keyword: Multiple Sclerosis; Genes & Behavior
Link ID: 9171 - Posted: 07.25.2006

Richard Van Noorden If you're one of the many people who while away hours playing FreeCell, that heinously addictive and complicated version of Solitaire, you may be interested to hear that some researchers think your performance in this computerized card game might reveal early signs of dementia. As Holly Jimison from the Oregon Center for Aging and Technology explains, scientists are looking for ways to spot mild loss of brain function, termed 'mild cognitive impairment' (MCI), before the full-blown symptoms of Alzheimer's disease emerge. This would allow doctors to plan their treatments earlier. That's a tricky task. MCI is poorly defined: it is not clear, for example, how much memory impairment should be considered abnormal, nor whether measured MCI will lead to Alzheimer's disease. "Standard memory tests, brain imaging and biological markers are all currently being used. There are a lot of interesting data but no solid answers," says William Jagust, a neuroscientist from the University of California, Berkeley. The Oregon researchers wanted to develop an unobtrusive continuous monitoring system that might reveal more reliable information than intensive, yearly memory check-ups. "We thought of using a suite of computer games," says Jimison. "So we interviewed elderly people, and FreeCell was by far their favourite. FreeCell requires a lot of mental planning to play, and it's cheap, non-invasive and fun." ©2006 Nature Publishing Group

Keyword: Alzheimers
Link ID: 9170 - Posted: 06.24.2010

Jennifer Wild A bout of post-traumatic stress disorder (PTSD) may do damage to the brain that kick-starts memory problems, scientists have discovered. Even patients who had recovered from a period of stress started to get age-related memory difficulties about a decade earlier than non-traumatized people, they report. Post-traumatic stress, a condition that can cause patients to feel physical pain on remembering a traumatic event, is known to have a number of effects on the mind and body. One of the side effects is that patients tend to be forgetful, unable to remember a story or a list of words after they've heard it, for example. This problem, which could come from emotional distraction and an inability to concentrate, can interfere with everyday tasks. Rachel Yehuda and her team at the Mount Sinai School of Medicine in New York decided to investigate further the link between PTSD and memory problems, by looking at what happens to patients as they age. Their study, due to be published in Biological Psychiatry1, looks at three groups of people: Holocaust survivors with continued PTSD, survivors who had recovered from their trauma, and a control group who had not lived through the Holocaust and had never had PTSD. The researchers looked at the study participants' ability to remember associations between common words such as 'desk and chair', a task that is known to become more difficult as we age. They tested their participants at the age of 67, and again at 72. ©2006 Nature Publishing Group

Keyword: Stress; Alzheimers
Link ID: 9169 - Posted: 06.24.2010

Helen Pearson A new study helps to explain why smokers tend to have boozier nights out than non-smokers. The work, done in rats, shows that a heavy dose of nicotine can cut blood-alcohol levels in half. If cigarettes similarly lower intoxication in people, it could mean that smokers need to drink more than non-smokers to get the same buzz. Many studies have shown that smokers tend to drink more alcohol than non-smokers, and a number of reasons are proposed for this. People who indulge in one habit may be simply more inclined to indulge in another, and socially both habits tend to go hand-in-hand at pubs and parties. Researchers also know that both nicotine and alcohol trigger a release of the feel-good brain chemical dopamine, but that indulging too much in either habit can breed tolerance to the drugs and reduce this pleasurable reward. So heavy users of one may boost use of the other to help bring their dopamine response back up. The research suggests that nicotine also directly alters the potency of alcohol in the body. Wei-Jung Chen of Texas A&M University, College Station, first saw hints of this in 1998, in a study of newborn rats given alcohol and nicotine1. ©2006 Nature Publishing Group

Keyword: Drug Abuse
Link ID: 9168 - Posted: 06.24.2010

Early dementia could be detected with a simple eye test, similar to those used to test for high blood pressure and diabetes, US scientists believe. The test, developed by a team led by Dr Lee Goldstein, of Brigham and Women's Hospital, Boston, uses a non-invasive laser to study the lens of the eye. It checks for deposits of beta-amyloid - the protein found in the brains of those with Alzheimer's disease. The procedure has worked in a trial in mice, a conference in Spain heard. During the trial, a brief pulse of infrared light into the eyes of four mice with Alzheimer's and four without accurately identified which had the condition. Dr Goldstein and his team envisage the test could be used to detect the disease at its earliest stages as well as to track disease progression and monitor how people respond to Alzheimer's treatments. Currently there is no simple test to make a diagnosis of dementia and it can only be confirmed with certainty by looking at someone's brain in a post-mortem examination. The scientists believe the technology, known as quasi-elastic light scattering, may detect the very earliest stages of amyloid deposits in the lens, even when they appear completely clear to the naked eye. The amyloid deposits appear as unusual cataracts. These are different from common, age-related cataracts. Dr Goldstein told the International Conference on Alzheimer's Disease and Related Disorders in Madrid: "Amyloid in the lens can be detected using extremely sensitive, non-invasive optical techniques. This makes the lens an ideal window for early detection and disease monitoring in Alzheimer's." (C)BBC

Keyword: Alzheimers
Link ID: 9167 - Posted: 07.24.2006